These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6139974)

  • 1. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin.
    Rose DP; Gottardis M; Noonan JJ
    Anticancer Res; 1983; 3(5):323-5. PubMed ID: 6139974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of thyroidectomy and prolactin suppression on the growth of N-nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP; Mountjoy KG
    Cancer Res; 1983 Jun; 43(6):2588-91. PubMed ID: 6850579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.
    Rose DP; Noonan JJ
    Cancer Res; 1982 Jan; 42(1):35-8. PubMed ID: 6797725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of rat mammary tumors associated with suppressed growth hormone.
    Phares CK
    Anticancer Res; 1986; 6(4):845-8. PubMed ID: 3019224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
    Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
    Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamines as mediators of the effect of prolactin and growth hormone on the growth of N-nitroso-N-methylurea-induced rat mammary tumor cultured in vitro in soft agar.
    Manni A; Wright C
    J Natl Cancer Inst; 1985 Apr; 74(4):941-4. PubMed ID: 3857388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment.
    Franks S; Horrocks PM; Lynch SS; Butt WR; London DR
    Lancet; 1981 Sep; 2(8248):659-61. PubMed ID: 6116045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Sweeney MJ; Poore GA; Kornfeld EC; Bach NJ; Owen NV; Clemens JA
    Cancer Res; 1975 Jan; 35(1):106-9. PubMed ID: 1109784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth enhancement of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar by estrogen or prolactin.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1984 Dec; 44(12 Pt 1):5605-8. PubMed ID: 6498820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mammary tumor growth by dexamethasone in rats in the presence of high serum prolactin levels.
    Aylsworth CF; Sylvester PW; Leung FC; Meites J
    Cancer Res; 1980 Jun; 40(6):1863-6. PubMed ID: 7371016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pergolide, a potent long-acting dopamine-receptor agonist.
    Lemberger L; Crabtree R; Callaghan JT
    Clin Pharmacol Ther; 1980 May; 27(5):642-51. PubMed ID: 7189453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Mayer RM; Diamond EJ; Hollander VP
    J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
    Okada H; Sakura Y; Kawaji H; Yashiki T; Mima H
    Cancer Res; 1983 Apr; 43(4):1869-74. PubMed ID: 6403230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of indomethacin on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Pérez-López FR; Lorenzo HK; Urcia MA; Hergueta J; Lafarga L; Guillen V
    Rev Esp Oncol; 1985; 32(1):15-21. PubMed ID: 3843001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primate mammary development. Effects of hypophysectomy, prolactin inhibition, and growth hormone administration.
    Kleinberg DL; Niemann W; Flamm E; Cooper P; Babitsky G; Valensi Q
    J Clin Invest; 1985 Jun; 75(6):1943-50. PubMed ID: 4008646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.